The traditional approach to patients with stage II endometrial carcinoma is
preoperative radiation therapy (RT) followed by surgery. Currently, many p
atients are treated with primary surgery and postoperative RT. We retrospec
tively reviewed the outcome of 44 stage II (32 IIA, 12 IIB) patients who un
derwent surgery and postoperative RT. Nine (20%) had microscopic cervical i
nvolvement noted before surgery, and 35 (80%) had occult involvement noted
postoperatively. Postoperative RT consisted of whole pelvic RT (WPRT) (50%)
, vaginal brachy-therapy (VB) (18%), or both (32%). At a median follow-up o
f 40 months, the 5-year actuarial disease-free survival was 72.4%. Two pati
ents (4%) had recurrence in the pelvis tone vagina, one lateral pelvis). Ei
ghteen stage IIA patients treated with WPRT alone and eight stage IIA patie
nts, without deep myometrial invasion (MI), were treated with VB alone, and
remained controlled in the pelvis. Extrapelvic recurrences occurred in 12
patients (25%), primarily in those with deep MI and/or grade 2-3 disease. O
ur results suggest that patients with stage II endometrial carcinoma with m
icroscopic or occult cervical involvement treated with surgery and postoper
ative RT have a favorable outcome. A high rate of pelvic control is achieve
d with RT tailored to the pathologic findings.